Bayer, Novartis Near Settlement Over MS Drug
Pharmaceutical companies Novartis AG and Bayer AG may soon be settling their differences over the production and marketing of multiple sclerosis drug Betaseron....To view the full article, register now.
Already a subscriber? Click here to view full article